NCT02123511 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Patients receive a placebo oral rinse and gargle or swish for 60 seconds and then spit 5 times per day beginning within 3 days of the initiation of radiotherapy to 14 days following completion of radiotherapy.
- id
- FG000
- title
- Arm A (Placebo)
- description
- Patients receive acetylcysteine oral rinse and gargle or swish for 60 seconds then spit 5 times per day beginning within 3 days of the initiation of radiotherapy to 14 days following completion of radiotherapy.
- id
- FG001
- title
- Arm B (Rincinol)
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Cancelled treatment
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 3
- type
- Incomplete data
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- type
- Ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 16
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- group Id
- FG001
- num Subjects
- 15
- type
- Eligible Patients
- achievements
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 12
- comment
- evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 4
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Patients receive a placebo oral rinse and gargle or swish for 60 seconds and then spit 5 times per day beginning within 3 days of the initiation of radiotherapy to 14 days following completion of radiotherapy.
- id
- FG000
- title
- Arm A (Placebo)
- description
- Patients receive acetylcysteine oral rinse and gargle or swish for 60 seconds then spit 5 times per day beginning within 3 days of the initiation of radiotherapy to 14 days following completion of radiotherapy.
- id
- FG001
- title
- Arm B (Rincinol)
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Cancelled treatment
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 3
- type
- Incomplete data
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- type
- Ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 16
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- group Id
- FG001
- num Subjects
- 15
- type
- Eligible Patients
- achievements
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 12
- comment
- evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 4
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle